DocMorris AG (0RRB) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

So good morning everybody here in Zurich and at the webcast. It's a pleasure for us to present our full year result 2025. With me today is Daniel Wurst, our CFO. My name is Walter Hess. I'm CEO. Let's go straight to the highlights of 2025. We delivered on our promises and we met the financial targets 2025. We achieved 11.1% of revenue growth and minus 48% adjusted EBTA. And with that, we achieved our guidance. The growth of RX was 33.2%. and of non-RX, 7.1%. The digital services, with a growth of 110%, so a remarkable growth rate again, and a significant profitability contribution, it's a contribution margin three, which is more than 50% already of the total company. Our AI health companion, which we have started to launch in October last year as a beta version in our app, has been adopted really very fast. Already every third app user is utilizing this AI health assistant. And with the strong liquidity position of 160 million Swiss francs by end of the year, we are very confident to execute in 2026 and 2027 according to our plans. We are fully aware of the challenging and also critical market environment. However, we today focus on the future, on our successful transition and on our path to breakeven, and to cash generation. We do that by giving you an update on our strategy first, followed by a business update, and then the financial update and outlook given by my colleague Daniel before we come to the Q&A session. There are some real important mega trends in healthcare, which have a big impact on our business. And we see us at the sweet spot of the three major mega trends. One is the demographic change, which gives a structural shift towards prevention and longevity, but mainly also towards a higher chronic care demand. It's the growth of the pharmaceutical market...